StockData
BioLineRx Ltd. logo

BioLineRx Ltd. (BLRX) stock

BLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 3/30
$0.96−0.10 (-9.07%)

Close on Nov 20, 2026Market cap $4.19MP/E –Yield –

BioLineRx net income

Net income is the profit left for shareholders after every expense, interest and tax.

No net income figures for BioLineRx

BioLineRx has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More BioLineRx figures

See a number that looks wrong?